This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2012-2015.
Location History:
- Lorrach, DE (2012)
- Basel, CH (2013)
- Lörrach, DE (2015)
Company Filing History:
Years Active: 2012-2015
Title: Esther Schmitt: Innovator in Cyclic Depsipeptides
Introduction
Esther Schmitt is a prominent inventor based in Loerrach, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of cyclic depsipeptides. With a total of 3 patents to her name, her work has the potential to impact the treatment of various diseases.
Latest Patents
Esther's latest patents focus on cyclic depsipeptides and their derivatives. One of her notable inventions is related to the structure of cyclic depsipeptides, which serve as inhibitors of kallikrein 7 and human neutrophil elastase. Another patent emphasizes the use of these cyclic depsipeptides to inhibit kallikrein 7, which can be crucial for treating kallikrein-7 dependent diseases.
Career Highlights
Esther Schmitt is currently associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to explore innovative solutions in drug development and contribute to advancements in therapeutic options.
Collaborations
Throughout her career, Esther has collaborated with several talented individuals, including Brigitta-Maria Liechty and Erwin Paul Schreiner. These collaborations have fostered a creative environment that enhances the research and development of new medicinal compounds.
Conclusion
Esther Schmitt's contributions to the field of cyclic depsipeptides exemplify her dedication to innovation in medicine. Her patents and collaborations highlight her role as a key figure in advancing therapeutic solutions.